Knight Therapeutics Inc.
KHTRF
$3.95
-$0.0924-2.29%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.94M | -22.61M | -15.52M | -12.73M | -12.27M |
| Total Depreciation and Amortization | 38.09M | 36.55M | 36.94M | 36.37M | 36.71M |
| Total Amortization of Deferred Charges | 662.90K | 648.30K | 648.30K | 648.30K | 648.30K |
| Total Other Non-Cash Items | -855.90K | 25.78M | 23.26M | 20.31M | 22.33M |
| Change in Net Operating Assets | -14.00M | -1.39M | 1.28M | 1.70M | -20.84M |
| Cash from Operations | 26.84M | 38.98M | 46.61M | 46.29M | 26.58M |
| Capital Expenditure | -1.85M | -1.77M | -1.67M | -1.28M | -702.60K |
| Sale of Property, Plant, and Equipment | 116.60K | 1.46M | 1.46M | 1.46M | 1.41M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.60M | -2.11M | 15.99M | 10.14M | 21.23M |
| Cash from Investing | 11.86M | -2.43M | 15.78M | 10.31M | 21.94M |
| Total Debt Issued | 3.47M | 2.93M | 4.00M | 4.69M | 4.80M |
| Total Debt Repaid | -21.52M | -25.65M | -25.97M | -23.94M | -22.82M |
| Issuance of Common Stock | 1.00M | 957.00K | 597.00K | 362.00K | 380.00K |
| Repurchase of Common Stock | -8.87M | -22.80M | -30.16M | -42.87M | -53.38M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.63M | -9.32M | -9.67M | -10.18M | -9.88M |
| Cash from Financing | -24.30M | -39.57M | -45.07M | -53.21M | -59.84M |
| Foreign Exchange rate Adjustments | 1.17M | 341.70K | 17.00K | 1.74M | 2.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.57M | -2.68M | 17.33M | 5.14M | -9.32M |